Related Experiment Video

Updated: Mar 3, 2026

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
08:37

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer

Published on: November 15, 2024

834

Hopefully devoted to Q: targeting glutamine addiction in cancer

Emma R Still1, Mariia O Yuneva1

  • 1Oncogenes and Tumour Metabolism Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

British Journal of Cancer
|April 26, 2017
PubMed

Insights

Cancer cells alter their metabolism to fuel growth, often relying on glutamine beyond glucose. Understanding glutamine metabolism is key for developing effective cancer therapeutics.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Biochemistry

Background:

  • Tumor cells exhibit altered metabolism to meet high energy and biosynthesis demands.
  • Research has primarily focused on glucose metabolism alterations in cancer.
  • Tumor metabolic requirements are complex, involving multiple pathways and metabolites.

Purpose of the Study:

  • To explore the intricate role of glutamine metabolism in cancer cells.
  • To discuss how tumor microenvironment influences glutamine dependency.
  • To inform the design of novel therapeutic strategies targeting cancer metabolism.

Main Methods:

  • Literature review of glutamine metabolism in tumor cells.
  • Analysis of the impact of tumor context on glutamine requirements.
  • Discussion of therapeutic implications.

Main Results:

  • Glutamine is essential for the proliferation and survival of many tumors, alongside glucose.
  • Tumor-specific contexts dictate the extent of glutamine utilization.
  • Targeting glutamine metabolism presents a viable therapeutic avenue.

Conclusions:

  • Glutamine metabolism is a critical, yet complex, aspect of cancer cell biology.
  • Therapeutic strategies must consider the multifaceted role of glutamine in different tumor types.
  • Further research into glutamine metabolism can lead to more effective cancer treatments.

More Related Videos

Glutamine Flux Imaging Using Genetically Encoded Sensors10:23

Glutamine Flux Imaging Using Genetically Encoded Sensors

Published on: July 31, 2014

10.1K
Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts06:32

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts

Published on: April 13, 2022

2.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
694
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
865
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
746